The Multiple Sclerosis Risk Sharing Scheme Monitoring Study – early results and lessons for the future
Open Access
- 6 January 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Neurology
- Vol. 9 (1), 1
- https://doi.org/10.1186/1471-2377-9-1
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Sex ratio of multiple sclerosis in Canada: a longitudinal studyThe Lancet Neurology, 2006
- Costs and quality of life of patients with multiple sclerosis in EuropeJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Defining the response to interferon‐β in relapsing‐remitting multiple sclerosis patientsAnnals of Neurology, 2006
- Disability progression in multiple sclerosis is slower than previously reportedNeurology, 2006
- Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis * Commentary: Evaluating disease modifying treatments in multiple sclerosisBMJ, 2003
- Problems with UK government's risk sharing scheme for assessing drugs for multiple sclerosisBMJ, 2003
- Interferons in relapsing remitting multiple sclerosis: a systematic reviewThe Lancet, 2003
- Population Laboratories and Health Needs AssessmentInternational Journal of Epidemiology, 1995
- THE NATURAL HISTORY OF MULTIPLE SCLEROSIS: A GEOGRAPHICALLY BASED STUDYBrain, 1991
- Rating neurologic impairment in multiple sclerosisNeurology, 1983